NCT03839602View on ClinicalTrials.gov

Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

May 1, 2001

Primary Completion Date

October 31, 2006

Study Completion Date

January 1, 2018

Conditions
Target Volume DelineationEarly-stage Nasopharyngeal CarcinomaIntensity Modulated Radiation Therapy
Interventions
RADIATION

Reducing CTV

CTVs were delineated in line with tumor stage, i.e. tumor invasion.

Trial Locations (1)

510060

Cancer Center, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT03839602 - Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients | Biotech Hunter | Biotech Hunter